Literature DB >> 826485

Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG.

Z Reggiardo, A K Shamsuddin.   

Abstract

The granulomagenic properties of serologically active glycolipids A1, B2, B3, and C isolated from Mycobacterium bovis BCG were studied. Glycolipid A1, dissolved in olive and injected intradermally in guinea pigs, was able to elicit a granulomatous response that seemed to be of the nonallergic type. This granulomagenic activity was quite striking since only 2 mug was necessary to elicit the reaction. The B and C glycolipids were milder granulomagenic agents. Glycolipid A1, dissolved in olive oil and injected intraperitoneally, was toxic for mice. Mice lost weight after the injection of as little as 10 mug of A1, although not even a dose of 100 mug was lethal. Glycolipid A1 failed to immunize mice against aerogenic infection with virulent tubercle bacilli.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826485      PMCID: PMC415540          DOI: 10.1128/iai.14.6.1369-1374.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3.

Authors:  I Azuma; E E Ribi; T J Meyer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

2.  Delayed-type hypersensitivity and immunity against aerogenic tuberculosis in guinea pigs.

Authors:  Z Reggiardo; G Middlebrook
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

3.  The formation and properties of macrophage polykaryons (inflammatory giant cells).

Authors:  M Mariano; W G Spector
Journal:  J Pathol       Date:  1974-05       Impact factor: 7.996

4.  Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.

Authors:  E Ribi; T J Meyer; I Azuma; R Parker; W Brehmer
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

5.  Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.

Authors:  T J Meyer; E Ribi; I Azuma
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

6.  Antibody formation to trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis.

Authors:  M Kato
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

7.  Granuloma formation induced in mice by chemically defined mycobacterial fractions.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; A Adam; E Lederer
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

8.  Effect of anti-cord factor antibody on experimental tuberculosis in mice.

Authors:  M Kato
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

9.  Acute granulomatous response produced in mice by trehalose-6,6-dimycolate.

Authors:  A Bekierkunst
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

10.  Serologically active glycolipid families from Mycobacterium bovis BCG. II. Serologic studies on human sera.

Authors:  Z Reggiardo; G Middlebrook
Journal:  Am J Epidemiol       Date:  1974-12       Impact factor: 4.897

View more
  3 in total

1.  Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra.

Authors:  K Kaneda; Y Sumi; F Kurano; Y Kato; I Yano
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Antitumor activity of mycobacterial glycolipid A1.

Authors:  Z Reggiardo
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

3.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.